These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3014483

  • 1. Early results of a trial of the Oka-strain varicella vaccine in children with leukaemia or other malignancies in Sweden.
    Heller L, Berglund G, Ahström L, Hellstrand K, Wahren B.
    Postgrad Med J; 1985; 61 Suppl 4():79-83. PubMed ID: 3014483
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vaccination of children with malignant disease against varicella.
    Slørdahl SH, Wiger D, Strømøy T, Degre M, Thørsby E, Lie SO.
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [Abstract] [Full Text] [Related]

  • 4. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy.
    Haas RJ, Belohradsky B, Dickerhoff R, Eichinger K, Eife R, Holtmann H, Goetz O, Graubner U, Peller P.
    Postgrad Med J; 1985; 61 Suppl 4():69-72. PubMed ID: 3014480
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M, Kamiya H, Baba K, Asano Y, Ozaki T, Horiuchi K.
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
    Gershon AA, Steinberg S, Gelb L, Galasso G, Borkowsky W, LaRussa P, Ferrara A.
    Postgrad Med J; 1985; 61 Suppl 4():73-8. PubMed ID: 3014482
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ.
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA, Steinberg SP, Gelb L.
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [Abstract] [Full Text] [Related]

  • 20. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I, Study Group for Varivax.
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.